Citations

Showing 10 of 108104 citations.

Abstract 330: Blood Oxygen Level Dependent (BOLD) MR evaluation of renal oxygenation is unaffected by water loading in atherosclerotic renovascular disease
Glockner, James F., Lerman, Lilach O. , Textor, Stephen C., Saad, Ahmed , Herrmann, Sandra M.

Mayo Clinic

Hypertension | March 20, 2022 | Volume: 64 | Issue: suppl_1 | Pages: No page available

10.1161/hyp.64.suppl_1.330 Get It

Background: Renal hypoxia is a complex function of post-glomerular medullary blood flow, active solute transport and is considered a major risk element for acute kidney injury. Previous studies indicate that sodium balance, diuretic administration and some drugs affect tissue oxygenation. Water loading in younger subjects lowers medullary deoxyhemoglobin. We sought to evaluate the effects of water loading on the day of BOLD imaging in older subjects undergoing protocol evaluation of atherosclerotic renovascular disease (ARVD). METHODS: Inpatient studies were performed in patients with hemodynamically severe ARVD (n=15, Doppler US velocity >270 cm/sec), during 150 mEq Na+ intake and ACE/ARB Rx. Two groups were studied: Group A (n=10) received oral water loading (20 ml/kg), whereas Group B (n=5) had none. Tissue R2* (index of deoxyhemoglobin levels) and fractional kidney hypoxia (medullary estimate) (% of renal coronal area with R2*>20/s) were measured in stenotic kidneys by BOLD-MRI at 3T, before and after IV injection of Furosemide (20gm). RESULTS: Cortical R2* and fractional tissue hypoxia were similar for the 2 groups (P =0.6 and 0.7). Both groups reduced cortical R2* and fractional hypoxia after furosemide injection to the same degree. Table CONCLUSION: These data demonstrate that water loading on the day of BOLD evaluation in older subjects with ARVD does not materially alter cortical or medullary estimates of oxygenation. Our results extend previous studies indicating that water loading in older individuals fails to alter medullary oxygenation unlike alterations in sodium intake, diuretic administration or blockade of the renin-angiotensin system.
Abstract 239: Natural Language Processing Identifies Important Side-effects In Very Elderly Patients With Hypertension,
Odunukan, Olufunso W. , Elayavilli, Ravikumar Komadur, Cha, Stephen, Rahman, Parvez, Roellinger, Daniel , Nyman, M. , Elayavilli, Ravikumar Komandur, Liu, Hongfang

Mayo Clinic

Hypertension | March 20, 2022 | Volume: 64 | Issue: suppl_1 | Pages: No page available

10.1161/hyp.64.suppl_1.239 Get It

Background: Concerns for side-effects makes the identification of treatment targets of hypertension in the very elderly challenging. We sought to utilize natural language processing (NLP) to evaluate the prevalence of prespecified side-effects in a cohort of very elderly (≥80 years) patients. Methods and Results: We conducted a two-year, cross-sectional study involving 5169 very elderly patients with and without hypertension seen by primary or specialist providers. Hypertension patients had to have a prior hypertension ICD-9 code in the electronic medical records problem list and ≥2 office visits in 2008 and 2009. We used NLP to analyze extracted free text reports from last clinic visits between 2008 and 2009. Of the 10 prespecified side-effects, hypotension, fatigue, and dizziness were the commonest three conditions and hypotension was significantly higher in the HTN patients. Of the 2835 patients with no prior hypertension history and 2334 hypertension patients identified, the prevalence of each prespecified item in both groups were: acute renal failure (0.3% v 0.6%, p=0.13); syncope (2.8% v 2.2%, p = 0.17), dizziness (3.1% v 4.0%, p=0.09), history of fall (1.0% v 0.9%, p=0.65), fatigue (5.4% v 4.5%, p=0.19), femoral neck fracture (0.18% v 0.04%, p=0.16), palpitations (1.2% v 1.5%, p=0.35), hypotension (4.1% v 6.6%, p<0.001), hyperkalemia (1.1% v 1.7%, p=0.04), hypokalemia (0.4% v 0.9%, p=0.01). At least one presumed side-effect was present in 17.5% of all 5169 patients. Among hypertension patients, there was no significant difference in the prevalence of the side-effects among patients with BP above (578) or below 140/90 (1756) except for acute renal failure (1.21% vs 0.40%, p = 0.03). Conclusion: Analysis of free-text outpatient notes using NLP showed that hypotension and potassium abnormalities were significantly more prevalent in very elderly patients with hypertension compared to similarly aged patients with no hypertension history.
Abstract P007: Hypertension and Myocardial Mechanics in Patients with Hypertrophic Cardiomyopathy
Manocha, Kevin K. , Snipelisky, David

Mayo Clinic

Hypertension | March 20, 2022 | Volume: 66 | Issue: suppl_1 | Pages: No page available

10.1161/hyp.66.suppl_1.p007 Get It

Introduction: Strain abnormalities in patients with Hypertrophic Cardiomyopathy (HCM) is associated with poor prognosis. Our aim was to assess whether the presence of hypertension in HCM altered myocardial mechanics using strain echocardiographic imaging. Hypothesis: Hypertension is a risk factor for diminished deformation in patients with HCM. Methods: A retrospective chart review of patients undergoing HCM evaluation at our facility between December 2008 and December 2011 was performed. Patients were divided into subsets based on the presence of hypertension as a documented diagnosis. All patients had comprehensive echocardiographic assessments with strain imaging. Clinical data was extracted from the electronic medical record. Comparisons in strain values were made between both subsets. Results: A total of 200 patients was assessed. The average age was 56 years (60% male) and 42.5% of the patients had a diagnosis of hypertension. Global longitudinal strain, Mid strain, Basal strain, Anterior, Lateral, Inferior, Inferolateral strain had no relation to the presence of hypertension. Septal strain (mean without hypertension -14.306 vs with hypertension -16.071, p value: .0069) Inferoseptal strain (mean without hypertension -12.813 vs with hypertension -15, p value: .0018), and Anteroseptal deformation (mean without hypertension -15.301 vs with hypertension -16.784, p value: .0445) however, was increased in patients with hypertension compared to patients with no history of hypertension (See Table) Conclusions: The presence of hypertension is associated with septal strain abnormalities. Thus, future exploration of hypertension control and hypertrophic cardiomyopathy prognosis and outcomes need to be explored.
Abstract 225: Patient Activation is Low and Associated With Early Post-discharge Outcomes in Patients Hospitalized With Acute Decompensated Heart Failure
Redfield, Margaret M. , Roger, Véronique L. , Dunlay, Shannon M. , Griffin, Joan M.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 20, 2022 | Volume: 9 | Issue: suppl_2 | Pages: No page available

10.1161/circoutcomes.9.suppl_2.225 Get It

Background: Recent studies have suggested that patient activation, or having the knowledge, skills and confidence to manage one’s own health, has a substantial impact on patient behaviors and health outcomes. However, the role of activation in patients with heart failure is unknown. Methods: We prospectively recruited Southeastern Minnesota residents hospitalized with acute decompensated heart failure (ADHF) from January 2014 through July 2015. Activation was measured by face-to-face questionnaire using the Patient Activation Measure (PAM) and patients were categorized into four activation levels (lowest to highest activation) per PAM guidelines. Logistic regression was used to examine the association between activation level and discharge location and early post-discharge outcomes. Results: Among the 302 patients enrolled, the mean age was 77.3 years, 57.3% were men, and 46.8% had preserved ejection fraction. Median (25th-75th percentile) length of stay was 4 (3-7) days and 7 (2.3%) patients died prior to discharge. Among survivors, 73.3% discharged to home, while the remainder went to skilled nursing facilities (23.0%), assisted living facilities (2.0%) or other arrangements (1.4%). The 30-day mortality rate was 7.0% and the 30-day readmission rate was 21.2%. The number (%) of patients in each activation category from highest to lowest was 9 (3.0%), 121 (40.1%), 122 (40.4%), and 50 (16.6%). Patients with lower activation were older, less educated, had worse overall and financial satisfaction, and worse health literacy. They more often discharged to skilled nursing facilities and had higher 30-day mortality, though 30-day readmission did not differ by activation (Figure). Adjusting for age, patients in the lowest activation level were at 3.1-fold increased odds of discharging to a skilled nursing facility and 6.0-fold increased odds of dying within 30 days of hospital discharge compared with patients in the highest two activation levels. Conclusions: Patients hospitalized with ADHF with lower activation are less satisfied, have worse health literacy, more often require skilled care and are at increased risk for early post-discharge mortality. Activation is easy to measure, identifies a high-risk subgroup, and is potentially modifiable.
Antihypertensive Pharmacogenetics: The C825T Polymorphism of G-Protein β 3 Subunit ( GNB3 ) Is Associated with Greater Blood Pressure (BP) Response to Diuretic Therapy in Essential Hypertens
Schwartz, Gary L. , Chapman, Arlene B. , Boerwinkle, Eric , Turner, Stephen T. , Chapman, Arlene B.

Mayo Clinic

Hypertension | March 20, 2022 | Volume: 36 | Issue: suppl_1 | Pages: 684-684

10.1161/hyp.36.suppl_1.684-c Get It

37 Knowledge of genetic factors that influence pharmacodynamics of responses to antihypertensive drugs may provide insights into molecular mechanisms contributing to elevation of BP and response to treatment. The T-allele of the C825T polymorphism of the gene coding for the G-protein β 3 subunit ( GNB3 ) has been associated with increased Na + -H + exchange and low plasma renin in individuals with EHT. Moreover, diminished counterregulatory activity of the renin-angiotensin system has been associated with greater BP declines in response to negative sodium balance induced by diuretic therapy. To assess the possible influence of GNB3 genotype on BP response to diuretic therapy, we measured the C825T polymorphism in community-based samples of 204 blacks (139 women, 65 men) and 192 whites (77 women, 115 men) with EHT (mean age=48±7 years) who underwent monotherapy with hydrochlorothiazide (HCTZ) for 4 weeks. In univariate analyses, the TT genotype was significantly associated with lower plasma renin activity ( p <0.001) and higher plasma aldosterone concentration ( p <0.019). In addition, mean declines in systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 6±2 mmHg ( p <0.001) and 5±1 mmHg ( p <0.001) greater, respectively, in TT than in CC homozygotes. Responses in heterozygotes were intermediate between homozygote groups. Other univariate predictors of greater declines in both SBP and DBP were higher pretreatment BP ( p <0.001), black race ( p <0.001), female gender ( p <0.005), older age ( p ≤0.064), lower waist/hip ratio (p≤0.087), and lower plasma renin activity ( p <0.001). Even after considering effects of these other predictors, the TT genotype remained associated with greater declines in SBP ( p <0.058) and DBP ( p <0.001). Thus, the C825T polymorphism of GNB3 may help identify individuals with EHT who are more responsive to diuretic therapy and may have Na + -dependent BP elevation.
Abstract 344: Optimal Serum Potassium, Calcium and Magnesium in the Coronary Care Unit
Krittanawong, Chayakrit , Park, Jae Y, Sharma, Sunita , Gaba, Prakriti , Rosenbaum, Andrew , Hu, Tiffany , Bell, Malcolm R. , Brady, Peter A. , Naksuk, Niyada , Krittanawong, Chayakrit , Thongprayoon, Charat , Herasevich, Vitaly , Kapa, Suraj , Asirvatham, Samuel J.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 20, 2022 | Volume: 8 | Issue: suppl_2 | Pages: No page available

10.1161/circoutcomes.8.suppl_2.344 Get It

Background: It is known that hypokalemia, hypocalcemia and hypomagnesemia cause a prolonged QTc interval and are associated with an increased risk of ventricular arrhythmias. However, there are limited data on optimal serum electrolytes for patients admitted to the coronary care unit (CCU). Objective: Here, we aimed to evaluate the relationship between serum potassium, ionized calcium and magnesium levels and in-hospital mortality in the CCU setting. Methods: This retrospective cohort study included 8,498 consecutive patients admitted to the CCU at an academic tertiary medical center from 2004 through 2013. The mean of serum electrolytes was categorized as <3.5, 3.5-<4.0, 4.0-<4.5 (reference), 4.5-<5.0, and ≥5.0 mEq/L for potassium; <4.4, 4.4-<4.6, 4.6-<4.8, 4.8-<5.0 (reference), and ≥5.0 mg/dL for ionized calcium; and <1.8, 1.8-<2.0, 2.0-<2.2 (reference), 2.2-<2.4, and ≥2.4 mg/dL for magnesium. Multivariate logistic regression analysis was used to determine the association between the mean of serum electrolytes and in-hospital mortality. Results: Of the 8,498 patients, 599 (7%) died during hospitalization. Relationship between mean serum potassium (U-shaped), ionized calcium (inverted J-shape) and magnesium (J-shaped) and in-hospital mortality was present in Figure. Serum potassium levels <3.5, 4.5-<5.0 and ≥5.0 mEq/L were independently associated with an increased risk of in-hospital mortality (adjusted OR 1.7 95% CI 1.1-2.5, OR 1.7 95% CI 1.3-2.2, and OR 3.4 95% CI 2.4-4.8, respectively), compared to the reference group. As for serum ionized calcium, the levels of <4.4, 4.4-<4.6, and 4.6-<4.8 mg/dL independently increased risk of mortality (adjusted OR 3.0 95% CI 2.3-4.0, OR 2.0 95% CI 1.5-2.6, and OR 1.4 95% CI, 1.1-1.8, respectively). As for serum magnesium, an only level above 2.4 mg/dL was associated with an increased mortality risk (OR 1.6 95% CI, 1.1-2.2). Conclusions: In the CCU setting, serum potassium 3.5-<4.5 mEq/L, ionized calcium ≥5.0 mg/dL and magnesium <2.4 mg/dL are associated with the lowest in-hospital mortality. These findings do not support supratherapeutic repletion of potassium and magnesium.
Abstract 283: Association of Body Mass Index with Outcomes in Patients with Atrial Fibrillation: Results From the ORBIT-AF Registry
Shrader, Peter, Thomas, Laine , Kowey, Peter R. , Sun, Shining, Burton, Paul , Piccini, Jonathan P. , Pandey, Ambarish , Gersh, Bernard J. , McGuire, Darren K. , Mahaffey, Kenneth W. , Hylek, Elaine M. , Peterson, Eric D. , Fonarow, Gregg C.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 20, 2022 | Volume: 8 | Issue: suppl_2 | Pages: No page available

10.1161/circoutcomes.8.suppl_2.283 Get It

Introduction: Higher body mass index (BMI) is an independent risk factor for incident atrial fibrillation (AF). However, its impact on management strategies and clinical outcomes among patients with prevalent AF is unclear. Methods: The study cohort included patients with AF enrolled in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry from June 2010 through August 2011. Participants with BMI > 18.5 kg/m2 were stratified into normal (18.5 - 25 kg/m2), overweight (25 - 30 kg/m2), Class I obese (30 - 35 kg/m2), Class II obese (35 - 40 kg/m2), and Class III obese (>40 kg/m2) categories. Unadjusted and adjusted Cox frailty models were constructed to assess the categorical and continuous association of BMI with AF progression, mortality, and incidence of thromboembolic events. Results: We evaluated 9,606 patients with AF (mean age: 74 + 11 years; 42% women) from 174 US ORBIT participating practices. Patients in the higher BMI categories were younger and had a higher prevalence of comorbidities such as diabetes, hypertension, and obstructive sleep apnea. AF symptom burden was greatest among patients in extreme BMI categories. Proportional use of anticoagulation, antiarrhythmic drugs, and invasive rhythm control strategies was significantly greater among patients in higher BMI categories. Rates for mortality and stroke/non-CNS embolism decreased in a near linear fashion across successively higher BMI categories (P<0.001; Table). After multivariable adjustment, higher BMI categories were associated with lower risk for mortality (p = 0.0002), with the lowest risk observed among overweight patients [Hazard Ratio (HR) (95% CI): 0.65 (0.54 - 0.79) ref. group: normal weight]. For every 5-kg/m2 increase in BMI, the odds of risk-adjusted mortality were 6% lower [HR (95% CI): 0.94 (0.89 - 0.98)]. In contrast, the association between BMI and risk for stroke/non-CNS embolism was significant on unadjusted analysis (P <0.001) but attenuated after adjustment for risk factors (P = 0.78; Table). No significant association was observed between BMI and AF progression rates in either unadjusted (P = 0.35) or adjusted analyses (P = 0.17). Conclusion: Among patients with AF, higher BMI was associated with a greater use of anticoagulation, rhythm control strategies, and lower mortality risk.
Abstract 369: Symptom Type and Characteristics Differentiate Early from Late Treatment Seekers for Symptoms of Atrial Fibrillation
McCabe, Pamela J. , Rhudy, Lori M. , Chamberlain, Alanna M. , DeVon, Holli A.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 20, 2022 | Volume: 7 | Issue: suppl_1 | Pages: No page available

10.1161/circoutcomes.7.suppl_1.369 Get It

Background: Delay in seeking treatment for symptoms of atrial fibrillation (AF) represents a missed opportunity for early treatment that is critical for reducing serious complications of AF such as stroke and heart failure. Delays ranging from a few days to years after symptom onset have been reported. Little is known about the symptom experiences and cognitive behavioral responses that differentiate those who seek treatment early after symptom onset from those who delay treatment-seeking. Purpose: This study compared symptoms and cognitive behavioral responses of early and late (up to 24 hours versus greater than 24 hours after symptom onset) treatment seekers with symptoms of AF. Methods: A descriptive design was used. Participants (N = 150) were recruited from a Midwest academic medical center. Data regarding 1) type and character of symptoms 2) cognitive and behavioral responses to the symptoms and 3) time from symptom onset to seeking treatment were collected using a structured interview. Independent t-tests for continuous variables and Chi-square tests for categorical variables were used to compare treatment seeking groups. Results: Participants were 51% female, with a mean age of 66.5 SD = 11.1) years. Early treatment seekers (n = 27) were more likely to experience a rapid heartbeat (p <.01), unremitting symptoms (<.001), report fear associated with symptoms (p = .005), and appraise symptoms as very serious (p <.001). They were less likely to believe symptoms could be self-managed (p <.001). Late treatment seekers (n = 123) were more likely to experience fatigue and dyspnea as primary symptoms (p≤ .01), report intermittent symptoms (p <.001), attribute symptoms to stress (p ≤ .02), deconditioning (p <.001), or lack of sleep (p = .009), and take a “wait and see” approach to managing symptoms (p <.001). There were no differences between early and late treatment seekers for age, sex, marital status, education level, and history of coronary artery disease or heart failure. Conclusions: Symptom type and characteristic, and cognitive behavioral responses of early treatment seekers differed from those of late treatment seekers. Experiencing a rapid heartbeat and unremitting symptoms may have helped participants form a cognitive appraisal and behavioral response conducive to early treatment-seeking. Experiencing intermittent symptoms less identifiable with a cardiac origin may have hindered development of cognitive appraisals and behavioral responses that promote early treatment- seeking. Education to promote early treatment-seeking for symptoms should include information about the diverse type and characteristics of symptoms of AF.
Abstract 355: Are Left Ventricular Assist Devices (LVAD) Underutilized in Heart Failure? A Pilot Survey of Provider Assessment of LVAD Candidacy and Referral
Foxen, Jilian L, Wagner, Jean, Gatzke, Janet, Nagel, Jill J., Prinsen, Jenny, Freund, Monique , Blank, Teresa, Houlihan, Robert J., Monnahan-Chicos, Randi, Birchem, Sandra, Kushwaha, Sudhir S. , Joyce, Lyle D., Redfield, Margaret M. , Freund, Monique

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 20, 2022 | Volume: 7 | Issue: suppl_1 | Pages: No page available

10.1161/circoutcomes.7.suppl_1.355 Get It

Background: Left ventricular assist device (LVAD) implantation is a new therapy for advanced heart failure (HF). The number of HF patients eligible for LVAD and the cardiology providers’ comfort level with referral for LVAD remains unclear. Objective: To assess provider perception of LVAD candidacy and LVAD referral patterns in consecutive HF patients. Methods: Providers completed a survey for each HF patient seen between March 1, 2013 and April 26, 2013. The survey listed standard LVAD candidacy criteria and asked 1) if a patient was an LVAD candidate (yes, no, unsure); 2) reasons patients were not LVAD candidates (check list, table); and 3) whether the patient had been referred for LVAD evaluation (yes, no, unsure). Results: Patients (n=522) were seen in a tertiary HF outpatient clinic (n=357; 68%), a tertiary HF inpatient service (n=36; 7%), a tertiary general cardiology service (n=45; 9%) or a community based outpatient cardiac clinic (n=84; 16%) Median age of patients was 73 years and 65% were male. Provider assessment of LVAD candidacy was “no” in 443 (85%), “yes” in 35 (7%) and “unsure” in 43 (8%) with ineligibility for LVAD attributed to multiple concerns (Table). Ninety percent of patients considered “too old” for LVAD were over 78 years of age. Provider designation of LVAD candidacy as yes or unsure varied across practice setting: tertiary HF outpatient clinic, 12%; tertiary HF inpatient service, 42%; tertiary general cardiology service, 22%; and community based outpatient cardiac clinic, 13%. In patients with a provider designation of LVAD candidacy as yes or unsure (n=78), only 21 (27%) patients had been referred for LVAD evaluation. Conclusion: When provided with LVAD candidacy criteria, providers indicated 15% of HF patients were (7%) or were possibly (8%) LVAD candidates but indicated that few patients had undergone a formal LVAD evaluation. These data suggest that measures to improve evaluation of HF patients for LVAD are needed.
Abstract 352: Clinician Attitudes and Self-Reported Practices Regarding End of Life Care in Heart Failure
Foxen, Jilian L, Cole, Terese, Feely, Molly A., Loth, Ann R., Strand, Jacob J. , Wagner, Jean, Redfield, Margaret M. , Dunlay, Shannon M. , Swetz, Keith M.

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | March 20, 2022 | Volume: 7 | Issue: suppl_1 | Pages: No page available

10.1161/circoutcomes.7.suppl_1.352 Get It

Background: Heart failure (HF) is a clinical syndrome with an overall poor prognosis, but the clinical trajectory is often unpredictable in individuals. There has been an impetus to promote iterative patient-provider discussions regarding preferences for end of life (EOL) care and advanced care planning. However, very little is known regarding provider preferences or their personal confidence addressing EOL care with their patients with HF. To address these gaps in knowledge, we surveyed clinicians at three practice sites in a large integrated health system. Methods: Physicians, nurse practitioners (NP), and physician assistants (PA) at Mayo Clinic (Rochester, Minnesota) and its surrounding health system were asked to participate in an electronic survey in October 2013. Clinicians surveyed included tertiary care HF specialists (Tertiary Care Cardiology), cardiologists and NP/PAs practicing in a community setting (Community Cardiology), and primary care clinicians (Primary Care). Results: A total of 95 clinicians completed the survey (52.5% response rate), including 50 physicians and 45 NP/PAs. Clinicians reported discussing prognosis and EOL wishes when their patient’s health status was worsening, but only 12% reported annual discussions as advocated by the American Heart Association. In total 52% of providers reported one or more reasons that they hesitate to discuss EOL care with their patients, including provider discomfort (11%), perception of patient (21%) or family (12%) unreadiness to have the discussion, fear of destroying hope (9%), or a lack of time (8%). Tertiary Care (63%) and Community Cardiology (58%) clinicians were more likely to attribute responsibility for having EOL discussions to the HF cardiologist, while 66% of Primary Care providers felt it was their responsibility. Tertiary and Community Cardiology clinicians were more likely to have referred patients to Palliative Medicine within the last year than Primary Care (89% vs. 21%, p<0.001). Overall, 30% of those surveyed reported low or very low confidence levels in initiating prognosis or EOL discussions, enrolling patients in hospice, or providing EOL care, with lower confidence among those with fewer years of clinical experience. The majority of clinicians expressed a high level of interest in further skills acquisition on these topics. Conclusion: There is tremendous variability in the way that clinicians view and approach advanced care discussions with their patients with HF; varying provider perception and lack of provider confidence may contribute. Despite this variability, most clinicians are interested in further development and skills acquisition. Addressing the learning needs of providers is an important next step toward enhancing the EOL care of patients with HF.